Description
Indications:
- Chronic Hepatitis C Virus (HCV) infection
- Used in combination therapy with other antiviral agents
Key Features:
- Potent and selective NS5A inhibitor
- Once-daily oral tablet
- High efficacy across HCV genotypes 1, 3, and others
- Enhances Sustained Virologic Response (SVR) when used in combination
Global Manufacturing & Export:
This product is manufactured in WHO-GMP accredited facilities designed per EU-GMP standards. Aetos Life Care exports Daclatasvir Tablets 60 mg to regulated and semi-regulated markets across Latin America, Africa, Asia, CIS, and the Middle East. The product complies with international quality, safety, and documentation requirements.
Third-Party Contract Manufacturing:
We offer third-party contract manufacturing for Daclatasvir Tablets 60 mg with customized branding, packaging, and regulatory support. Our flexible and scalable production capabilities make us a reliable partner for international pharmaceutical companies seeking high-quality, compliant antiviral products.
Storage Instructions:
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
